Contract Manufacturing Industry News
-
Pliaglis Regulatory Update FDA Sets PDUFA Date Of April 16, 2012
2/22/2012
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, recently announced an update to Pliaglis regulatory approval in the U.S. and the E.U.
-
Evotec And IR Pharma Establish Drug Discovery Alliance In The Field Of Respiratory
2/22/2012
Evotec AG and IR Pharma recently announced that they have entered into an exclusive strategic alliance to provide integrated drug discovery solutions to Pharmaceutical and Biotech companies in the field of Respiratory Diseases.
-
Catalent Completes Acquisition Of Clinical Trials Supplies Business Of Aptuit LLC
2/22/2012
Catalent Pharma Solutions recently announced that it has completed the acquisition of the Clinical Trial Supplies business of Aptuit LLC.
-
PCI Sponsors MassBio's Massachusetts CRO/CMO Symposium
2/22/2012
PCI (www.pcisynthesis.com), a 12-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, today announced its major sponsorship of the inaugural one-day Massachusetts Biotechnology Council (MassBio) CRO/CMO Symposium.
-
Lonza Confirms Talks With South African Government Regarding The Establishment Of A Joint Venture
2/15/2012
Lonza confirms to be in discussions and negotiations with the South African Government regarding the establishment of a local joint venture called Ketlaphela for the establishment of a local manufacturing facility for Anti-Retroviral Medicines.
-
Hikal’s API Manufacturing Site In Bangalore Completes 3rd Successful US FDA Inspection.
2/10/2012
Hikal Limited, a leading manufacturer of active ingredients, intermediates and regulated starting materials successfully completed its 3rd US FDA audit at its manufacturing facility located at Jigani, Bangalore.
-
NextPharma Technologies Hosts Inauguration Ceremony To Mark Official Opening Of Its ‘State Of The Art’ Cold Chain And Logistics Warehouse In Werne, Germany
2/3/2012
NextPharma, the leading European provider of product development, contract manufacturing and cold chain and logistics outsourcing services to the pharmaceutical and biotechnology industries, is pleased to announce the official opening of its "state of the art" Cold Chain and Logistics (CLS) warehouse in Werne, Germany at an inauguration ceremony attended by local dignitaries and many of NextPharma's customers.
-
OctoPlus Enters Into Drug Development And Manufacturing Contract With Ferring Pharmaceuticals A/S
2/3/2012
OctoPlus N.V. ("OctoPlus" or the "Company") (Euronext: OCTO), announces today that a formulation development and manufacturing contract has been signed with Ferring Pharmaceuticals A/S, a leading innovative pharmaceutical company.
-
Encap Drug Delivery Adds New Commercial Product To Portfolio
2/1/2012
Encap Drug Delivery, the world’s leading contract development and manufacturing organization (CDMO) totally dedicated to liquid and semi-solid (hot melt) filled capsules, announces the addition of a further pharmaceutical product to its portfolio of commercial products.
-
Aptar Pharma Expands Presence In India With A New Manufacturing Site Near Mumbai
1/25/2012
Aptar Pharma, world leader in the development and manufacturing of nasal and pulmonary drug delivery devices, recently announces the opening of a new facility near Mumbai, India.
This website uses cookies to ensure you get the best experience on our website. Learn more